EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis

Tate M Johnson iD, Halie Frideres iD, Punyasha Roul, Joshua F Baker, Brian C Sauer iD, Grant W Cannon iD, Isaac D Smith, Gary A Kunkel, Beth I Wallace, Thomas R Porter, Kaveh R Bookani, Amarnath R Annapureddy und 2 weitere

Arthritis & Rheumatology · 2026-07 · 78 (7) · 1437-1445

DOI: 10.1002/art.70081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 17.02.2026. Verfasst von Tate M Johnson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Affairs (VA) Nebraska-Western Iowa Health Care System, Omaha, Nebraska. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, U.S. Department of Defense, RRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Evaluate performance of the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator in rheumatoid arthritis (RA).

Methods

Patients with RA were matched up to 10 controls on age, sex, and enrollment year using National Veterans Health Administration, Medicare, and National Death Index data (2006–2020). Ten‐year estimated cardiovascular disease (CVD) risk was calculated using PREVENT. Calibration (standardized incidence ratio [SIR] and observed/predicted events) and discrimination (sensitivity and Harrel's C‐statistics) were compared between RA cases and controls. PREVENT performance was compared with the Pooled Cohort Equations (PCE) for atherosclerotic CVD (ASCVD) prediction in RA, including net reclassification index (NRI) calculation.

Results

Among 30,687 patients with RA and 231,752 patients without RA, 28,061 ASCVD and 13,851 heart failure (HF) outcomes were identified over >2 million person‐years. PREVENT underestimated overall CVD (SIR 1.83, 95% confidence interval [CI] 1.79–1.88), ASCVD (SIR 2.25, 95% CI 2.19–2.32) and HF risk (SIR 1.41, 95% CI 1.36–1.46) to a greater degree in RA compared with controls and exhibited poor sensitivity for ASCVD (61.9%) and HF (63.2%) development. PREVENT performance was poorer for ASCVD prediction compared with the PCE (SIR 1.38, 95% CI 1.34–1.41, sensitivity 76.0%). NRI for PREVENT was modest (5.3%). Among 657 reclassified patients who experienced ASCVD, 626 were inappropriately reclassified as low or borderline risk. PREVENT performance significantly improved when including hemoglobin A1c (overall CVD: SIR 1.21, 95% CI 1.18–1.24; ASCVD: SIR 1.45, 95% CI 1.41–1.50; HF: SIR 0.79, 95% CI 0.76–0.82; sensitivity ASCVD 80.3%).

Conclusion

PREVENT underestimates CVD risk in RA, consistent with suboptimal performance of existing risk calculators. Preferential use of PREVENT including hemoglobin A1c should be considered. Improving CVD risk stratification in RA remains a high priority.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidCardiovascular DiseasesHumansFemaleRisk AssessmentMaleAgedMiddle AgedUnited StatesHeart FailureHeart Disease Risk Factors

Autor:innen und Institutionen

  • Veterans Affairs (VA) Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
  • Division of Rheumatology & Immunology, University of Nebraska Medical Center, Omaha.
  • Corporal Michael J. Crescenz VA Medical Center, University of Pennsylvania, Philadelphia.
  • Salt Lake City VA Health Care, University of Utah, Salt Lake City.
  • Durham VA Health Care System, Durham, North Carolina.
  • VA Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan.

ORCID-Profile: Tate M Johnson, Halie Frideres, Brian C Sauer, Grant W Cannon, Ted R Mikuls, Bryant R England

Förderung

  • CSRD VA
  • U.S. Department of Defense
  • RRD VA
  • BLRD VA
  • Rheumatology Research Foundation
  • U.S. Department of Veterans Affairs
  • Duke Center for Research to Advance Healthcare Equity
  • NIGMS NIH HHS

Zitieren

APA

Johnson, T. M., Frideres, H., Roul, P., Baker, J. F., Sauer, B. C., Cannon, G. W., Smith, I. D., Kunkel, G. A., Wallace, B. I., Porter, T. R., Bookani, K. R., Annapureddy, A. R., Mikuls, T. R., & England, B. R. (2026). Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis. Arthritis & Rheumatology, 78(7), 1437-1445. https://doi.org/10.1002/art.70081

Vancouver

Johnson TM, Frideres H, Roul P, Baker JF, Sauer BC, Cannon GW, et al. Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis. Arthritis & Rheumatology. 2026;78(7):1437-1445. doi:10.1002/art.70081

BibTeX
@article{Johnson2026,
  author = {Johnson, Tate M and Frideres, Halie and Roul, Punyasha and Baker, Joshua F and Sauer, Brian C and Cannon, Grant W and Smith, Isaac D and Kunkel, Gary A and Wallace, Beth I and Porter, Thomas R and Bookani, Kaveh R and Annapureddy, Amarnath R and Mikuls, Ted R and England, Bryant R},
  title = {Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  volume = {78},
  number = {7},
  pages = {1437--1445},
  doi = {10.1002/art.70081}
}
Kostenlos starten →